Matches in SemOpenAlex for { <https://semopenalex.org/work/W3134835711> ?p ?o ?g. }
- W3134835711 endingPage "117385" @default.
- W3134835711 startingPage "117385" @default.
- W3134835711 abstract "To minimize the risk of Progressive Multifocal Leukoencephalopathy and rebound in JCV-positive multiple sclerosis (MS) patients after 24 natalizumab doses, it has been proposed to extend the administrations interval. The objective is to evaluate the EID efficacy on MRI activity compared with the standard interval dosing (SID).Observational, multicentre, retrospective cohort study, starting from the 24th natalizumab infusion to the loss of follow-up or 2 years after baseline. Three hundred and sixteen patients were enrolled. The median dose interval (MDI) following the 24th infusion was 5 weeks, with a bimodal distribution (modes at 4 and 6 weeks). Patients were grouped into 2 categories according to the mean number of weeks between doses: <5 weeks, SID; ≥5 weeks, EID.One hundred and eighty-seven patients were in the SID group (MDI = 4.5 weeks) and 129 in the EID group (MDI 6.1 weeks). The risk to develop active lesions on MRI is similar in SID and EID groups during the 6 and 12 months after the 24th natalizumab infusion, respectively 4.27% (95% CI:0.84-7.70) vs 4.71% (95% CI:0.16-9.25%) [p = 0.89] and 8.50% (95% CI:4.05-12.95) vs 6.55% (95% CI:2.11-11.00%) [p = 0.56]. The EID regimen does not appear to increase the occurrence of MRI activity during follow-up.There is no evidence of the reduced efficacy of natalizumab in an EID setting regarding the MRI activity. This observation supports the need for a bigger randomized study to assess the need to change the standard of the natalizumab dosing schedule, to better manage JCV-positive patients." @default.
- W3134835711 created "2021-03-15" @default.
- W3134835711 creator A5001834406 @default.
- W3134835711 creator A5003704445 @default.
- W3134835711 creator A5008399113 @default.
- W3134835711 creator A5008670972 @default.
- W3134835711 creator A5009851506 @default.
- W3134835711 creator A5020691493 @default.
- W3134835711 creator A5022266805 @default.
- W3134835711 creator A5024633714 @default.
- W3134835711 creator A5027720251 @default.
- W3134835711 creator A5028388712 @default.
- W3134835711 creator A5029894629 @default.
- W3134835711 creator A5031754069 @default.
- W3134835711 creator A5038394370 @default.
- W3134835711 creator A5040947413 @default.
- W3134835711 creator A5043602703 @default.
- W3134835711 creator A5047585580 @default.
- W3134835711 creator A5048070907 @default.
- W3134835711 creator A5049481601 @default.
- W3134835711 creator A5049964338 @default.
- W3134835711 creator A5055525749 @default.
- W3134835711 creator A5059668121 @default.
- W3134835711 creator A5063501464 @default.
- W3134835711 creator A5067420465 @default.
- W3134835711 creator A5082323154 @default.
- W3134835711 creator A5083744505 @default.
- W3134835711 creator A5086425939 @default.
- W3134835711 creator A5088425753 @default.
- W3134835711 creator A5088979800 @default.
- W3134835711 date "2021-05-01" @default.
- W3134835711 modified "2023-10-18" @default.
- W3134835711 title "MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study" @default.
- W3134835711 cites W1970547229 @default.
- W3134835711 cites W1978838993 @default.
- W3134835711 cites W2008104237 @default.
- W3134835711 cites W2142243006 @default.
- W3134835711 cites W2169726349 @default.
- W3134835711 cites W2179093540 @default.
- W3134835711 cites W2777074421 @default.
- W3134835711 cites W2971172353 @default.
- W3134835711 cites W3045485528 @default.
- W3134835711 doi "https://doi.org/10.1016/j.jns.2021.117385" @default.
- W3134835711 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33770708" @default.
- W3134835711 hasPublicationYear "2021" @default.
- W3134835711 type Work @default.
- W3134835711 sameAs 3134835711 @default.
- W3134835711 citedByCount "6" @default.
- W3134835711 countsByYear W31348357112021 @default.
- W3134835711 countsByYear W31348357112022 @default.
- W3134835711 countsByYear W31348357112023 @default.
- W3134835711 crossrefType "journal-article" @default.
- W3134835711 hasAuthorship W3134835711A5001834406 @default.
- W3134835711 hasAuthorship W3134835711A5003704445 @default.
- W3134835711 hasAuthorship W3134835711A5008399113 @default.
- W3134835711 hasAuthorship W3134835711A5008670972 @default.
- W3134835711 hasAuthorship W3134835711A5009851506 @default.
- W3134835711 hasAuthorship W3134835711A5020691493 @default.
- W3134835711 hasAuthorship W3134835711A5022266805 @default.
- W3134835711 hasAuthorship W3134835711A5024633714 @default.
- W3134835711 hasAuthorship W3134835711A5027720251 @default.
- W3134835711 hasAuthorship W3134835711A5028388712 @default.
- W3134835711 hasAuthorship W3134835711A5029894629 @default.
- W3134835711 hasAuthorship W3134835711A5031754069 @default.
- W3134835711 hasAuthorship W3134835711A5038394370 @default.
- W3134835711 hasAuthorship W3134835711A5040947413 @default.
- W3134835711 hasAuthorship W3134835711A5043602703 @default.
- W3134835711 hasAuthorship W3134835711A5047585580 @default.
- W3134835711 hasAuthorship W3134835711A5048070907 @default.
- W3134835711 hasAuthorship W3134835711A5049481601 @default.
- W3134835711 hasAuthorship W3134835711A5049964338 @default.
- W3134835711 hasAuthorship W3134835711A5055525749 @default.
- W3134835711 hasAuthorship W3134835711A5059668121 @default.
- W3134835711 hasAuthorship W3134835711A5063501464 @default.
- W3134835711 hasAuthorship W3134835711A5067420465 @default.
- W3134835711 hasAuthorship W3134835711A5082323154 @default.
- W3134835711 hasAuthorship W3134835711A5083744505 @default.
- W3134835711 hasAuthorship W3134835711A5086425939 @default.
- W3134835711 hasAuthorship W3134835711A5088425753 @default.
- W3134835711 hasAuthorship W3134835711A5088979800 @default.
- W3134835711 hasConcept C118552586 @default.
- W3134835711 hasConcept C126322002 @default.
- W3134835711 hasConcept C126838900 @default.
- W3134835711 hasConcept C143409427 @default.
- W3134835711 hasConcept C167135981 @default.
- W3134835711 hasConcept C168563851 @default.
- W3134835711 hasConcept C23131810 @default.
- W3134835711 hasConcept C2777288759 @default.
- W3134835711 hasConcept C2780640218 @default.
- W3134835711 hasConcept C2780644213 @default.
- W3134835711 hasConcept C2781004633 @default.
- W3134835711 hasConcept C2781413609 @default.
- W3134835711 hasConcept C44249647 @default.
- W3134835711 hasConcept C71924100 @default.
- W3134835711 hasConcept C72563966 @default.
- W3134835711 hasConceptScore W3134835711C118552586 @default.
- W3134835711 hasConceptScore W3134835711C126322002 @default.
- W3134835711 hasConceptScore W3134835711C126838900 @default.